Approved for 13 hours of AANP CME for NDs through November 1st 2023 (2 hours of pharmacy, 1 hour ethics)
This video series is designed as a cohesive course covering diagnosis, common comorbidities and rare/serious complications of hypermobile connective tissue disorders. We understand that providers of various backgrounds and knowledge levels are interested in all or parts of this work, so we have created separate modules of content. The course covers basic to more advanced discussion and complexity. Some participants are ready to step into the basics and others are ready to jump right into the advanced topics.
We will cover the following topics in detail: genetic hypermobile connective tissue disorders including hypermobile Ehlers Danlos Syndrome (hEDS), genetic subtypes of EDS, physical exam skills, dysautonomia and postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), CSF leaks, gastrointestinal dysmotility, upper cervical spine instability (craniocervical and atlantoaxial instability), Chiari malformation, tethered cord, small fiber neuropathy, intracranial hypertension, and vascular compression syndromes such as median arcuate ligament syndrome and nutcracker syndrome. We discuss diagnosis and ancillary testing. We will cover integrative and pharmaceutical treatment options, physical therapy and movement modalities, lifestyle interventions and when and how to consider medical and surgical interventions. Participants will leave with increased diagnostic and treatment skills they can apply in clinic immediately.
Co-taught by
Alena Guggenheim, ND
Board certified Rheumatologist
Carla Guggenheim, DO
Moderated by Fiona Campbell, ND.
Guest lecture by Juliana Kilmurray.
What you'll get:
The Lectures
-
Lecture 1 Clinical signs and symptoms
Clinical signs and symptoms of hypermobile connective tissue disorders, epidemiology and overview of comorbidities that will be covered
-
Lecture 2 Diagnostic Criteria
Deep dive into diagnostic criteria for hypermobile Ehlers-Danlos syndrome (hEDS), Hypermobile Spectrum Disorder (HSD), genetic Ehlers-Danlos Subtypes
-
Lecture 3 Physical Exam
Physical exam skill building: joint exam, use of the goniometer
-
Lecture 4 The ethics of ableism (guest speaker Juliana Kilmurray)
The ethics of working with the chronic disease population. Recognition of provider ableism and the impacts on patient care
-
Lecture 5 Dysautonomia
Clinical signs and symptoms of dysautonomia, diagnostic evaluation and interpretation of autonomic reflex testing
-
Lecture 6 Dysautonomia pharmacology
Pharmacology of autonomic agents used in the treatment of dysautonomia
-
Lecture 7 Mast cell activation syndrome
Recognition of Mast Cell Activation Syndrome (MCAS)
-
Lecture 8 Mast cell pharmacology
Pharmacology of mast cell mitigating medications, choice of therapy and management
-
Lecture 9 Overview of advanced topics
Overview of advanced topics covered: small fiber neuropathy, neurological complications of HSD, nerve and vascular compression syndromes, gastrointestinal complications
-
Lecture 10 Small fiber neuropathy
Recognition, diagnosis and treatment implications of small fiber neuropathy
-
Lecture 11 Vascular and nerve compression syndromes
Recognition, diagnosis and management of nerve and vascular compression syndromes: peripheral nerve compression (ulnar, median), thoracic outlet syndrome, median arcuate ligament syndrome, nutcracker syndrome
-
Lecture 12 Neurological complications
Recognition and management of upper cervical complications and tethered cord: craniocervical instability, atlantoaxial instability, eagle syndrome, Chiari malformation, idiopathic intracranial hypertension (IIH), tethered cord
-
Lecture 13 Spontaneous Intracranial Hypotension
Spontaneous Intracranial Hypotension (SIH): when the dura is not durable. Clinical symptoms of SIH, diagnostic imaging evaluation and management strategies
-
Lecture 14 Gastrointestinal complications
Gastrointestinal complications: dysmotility, small intestinal bacterial overgrowth
-
Lecture 15 Gastrointestinal pharmacology
Pharmaceutical management of dysmotility and SIBO
-
Lecture 16 Final Q &A